Radiation therapy for angiosarcoma
β Scribed by Jon R. Ward; Steven J. Feigenberg; Nancy Price Mendenhall; Robert B. Marcus Jr.; William M. Mendenhall
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 87 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background.
Between 1964 and 1998, 19 patients with histologically proven angiosarcoma were treated with curative intent with radiation therapy.
Methods.
Median followβup was 37 months (range, 8β234 months).
Results.
The actuarial 5βyear absolute survival and local control rates were 51% and 50%, respectively. Of 12 patients who relapsed, 8 had isolated local recurrence as the first site of treatment failure, 2 had local (1 patient) or regional recurrence in conjunction with distant metastases, and 2 had distant metastases alone. Two of four patients who underwent further therapy for recurrent disease were successfully salvaged.
Conclusions.
Only the location of the primary tumor was a predictor of local control and absolute survival at 5 years. Angiosarcomas located on the scalp imply a dismal prognosis compared with those in other locations with the predominant pattern of failure being local recurrence. Patients should be treated aggressively with surgical resection and preoperative or postoperative radiation therapy. Β© 2003 Wiley Periodicals, Inc. Head Neck 25: 873β878, 2003
π SIMILAR VOLUMES
Three cases of angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma are presented. Only two similar cases have been documented. The role of radiation therapy and chronic lymphedema is discussed. Although the overall survival is usually less than 22 months, two of thes
## Angiosarcoma of the Breast after Lumpectomy and Radiation Therapy for Adenocarcinoma We read with interest the recent report by Drs. Stokkel and Peterse regarding three cases of angiosarcoma of the breast that occurred after lumpectomy and postoperative radiation therapy for treatment of primar
## Abstract ## BACKGROUND Angiosarcoma arising in the irradiated breast after breastβconserving therapy is being reported with increasing frequency. As more women undergo breastβconserving therapy, the incidence can be expected to increase. Surgeons, medical oncologists, and radiation oncologists